Lipid-lowering therapy in outpatients of different ages with coronary artery disease
| Autor: | S. K. Zyryanov, S. B. Fitilev, A. V. Vozzhaev, I. I. Shkrebniova, N. N. Landyshev, Ya. G. Voronko, A. M. Lutsenko |
|---|---|
| Jazyk: | ruština |
| Rok vydání: | 2020 |
| Předmět: | |
| Zdroj: | Кардиоваскулярная терапия и профилактика, Vol 19, Iss 5 (2020) |
| Druh dokumentu: | article |
| ISSN: | 1728-8800 2619-0125 58687246 |
| DOI: | 10.15829/1728-8800-2020-2654 |
| Popis: | Aim. To conduct a pharmacoepidemiologic analysis of lipid-lowering therapy (LLT) in outpatients of different ages with coronary artery disease (CAD).Material and methods. A total of 805 medical records of outpatients with CAD were analyzed in this pharmacoepidemiologic, cross-sectional study conducted at primary care facility of Moscow. The total sample of patients was divided into 3 age groups: group 1 — 0,05). Dual LLT was prescribed rarely (4,9%, 3,9%, 0,9%, respectively), especially in patients ≥75 years (p0,05); patients ≥75 received rosuvastatin less often (p0,05), as well as the proportion of patients not achieved target LDL-C 0,05).Conclusion. The study demonstrated no significant influence of patient age on LLT prescription rates, LDL-C control, and prevalence of irrational drug combinations in outpatients with CAD. Rates of dual LLT, structure and intensity of statin therapies differed depending on age groups. |
| Databáze: | Directory of Open Access Journals |
| Externí odkaz: |
|